Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NP48925a Hereditary Angioedema Branded Medicines (Orladeyo)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

13 May 2025 at 01:00

OJEU - F3 - Contract Award Notice
Award

04 Apr 2025 at 01:00

OJEU - F15 - Voluntary Ex Ante Transparency Notice
Summary of the contracting process

The procurement process for the provision of Hereditary Angioedema Branded Medicines (Orladeyo) has been completed under the auspices of The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), based in Edinburgh. This procurement was conducted under a framework agreement and was identified as contract NP48925a, focusing on the health industry category. The contract was awarded on 4th April 2025 to BioCryst UK Ltd, highlighting a targeted approach to supply critical medicines. The procurement was managed under a limited method, without prior publication due to the protection of exclusive rights, aligning with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015. This was an award stage, with the process culminating in an active contract valued at approximately £1,582,400, covering entities under the National Health Service (Scotland) Act 1978.

This procurement presents a significant opportunity for businesses involved in the production and supply of specialised pharmaceutical products, particularly those with exclusive medicinal formulations like berotralstat 150mg capsules. The tender could be particularly favourable for large-scale enterprises with the capability to meet high-volume demands and navigate the complexities of exclusive rights in pharmaceuticals. Companies positioned within the health sector and experienced in engaging with NHS Scotland will find this sector ripe for exploring further collaborative opportunities. As this process demonstrates the critical role of intellectual property rights, entities with a robust legal understanding and capabilities to protect proprietary medicinal products will be advantaged in similar tenders.

How relevant is this notice?

Notice Information

Notice Title

NP48925a Hereditary Angioedema Branded Medicines (Orladeyo)

Notice Description

Supply of Hereditary Angioedema Branded Medicines to NHS Scotland: NP48925a Hereditary Angioedema Branded Medicines (Orladeyo(r))

Lot Information

Lot 1

The Framework Agreement is for the supply of berotralstat 150mg capsules (Orladeyo) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Procurement Information

The medicine awarded to the Framework Agreement is protected by exclusive rights, including intellectual property rights, in accordance with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000794845
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY530236
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1,582,400 £1M-£10M

Notice Dates

Publication Date
13 May 20251 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
4 Apr 20251 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
1
Supplier Name

BioCryst UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...